Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Patients 2-5 Years of Age
.
Show all posts
Showing posts with label
Patients 2-5 Years of Age
.
Show all posts
Tuesday, September 24, 2019
PTC Therapeutics Receives FDA Approval for the Expansion of the Emflaza (deflazacort) Labeling to Include Patients 2-5 Years of Age
›
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that the U.S. Food and Drug Administration (FDA) approved the company's s...
›
Home
View web version
